e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Rare diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic Pneumonia Syndrome after hematopoietic sten cell transplantation
M. Yomota (Tokyo, Japan)
Source:
International Congress 2017 – Rare diseases
Session:
Rare diseases
Session type:
Thematic Poster
Number:
3848
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Yomota (Tokyo, Japan). Idiopathic Pneumonia Syndrome after hematopoietic sten cell transplantation. 3848
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Timeline of pulmonary complications after hematopoietic stem cell transplantation in children
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016
Influence of respiratory viruses on airflow decline after allogenic hematopoietic stem cell transplantation
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 470-472
Year: 2011
Utility of biomarkers in the management of respiratory diseases in hematopoietic stem cell transplant
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience
Source: Eur Respir J, 53 (2) 1801096; 10.1183/13993003.01096-2018
Year: 2019
Bronchiolitis obliterans following haematopoietic stem cell transplantation
Source: Eur Respir J 2007; 29: 1007-1019
Year: 2007
Septic pulmonary embolisms as a cause of acute respiratory distress syndrome
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Respiratory infections in autologus stem cell transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004
Late Breaking Abstract - Cytomegalovirus reactivation in COVID-19 patients with Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – Severe acute respiratory failure
Year: 2021
Acute Respiratory Distress Syndrome in Mechanically-Ventilated Patients with Community-Acquired Pneumonia
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept